ERα-IN-3
ERα-IN-3 is a ERα inhibitor with an IC50 of 74.48 μM. ERα-IN-3 induces cell cycle arrest at the G0/G1 and G2/M checkpoints and triggers Apoptosis. ERα-IN-3 exhibits anticancer effects against ER-positive breast cancer. ERα-IN-3 can be used for the research of ERα-positive breast cancer.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C25H21N3O4
- 分子量:427.45
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
|
ERα 74.48 μM (IC50) |
ERα-IN-3 (Compound 20) at concentrations of 2-32 μM potently inhibits the proliferation of ER-positive breast cancer cell line T-47D, with an IC50 value of 9.666 μM. Its activity in this cell line is superior to that of Tamoxifen (HY-13757A) and Bazedoxifene (HY-A0031)[1].
ERα-IN-3 inhibits ERα with an IC50 value of 74.48 μM[1].
ERα-IN-3 (25 μM; 48 h) induces cell cycle arrest in T-47D cells, primarily at the G0/G1 phase (59.7%), with additional arrest at the G2/M phase (26.3%)[1].
ERα-IN-3 (25 μM; 48 h) induces apoptosis in approximately 40% of T-47D breast cancer cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:T-47D
-
Concentration:25 μM
-
Incubation Time:48 h
-
Result:Induced cell cycle arrest with 59.7% of cells in the G0/G1 phase, 9.8% in the S phase, and 26.3% in the G2/M phase.
-
Cell Line:T-47D
-
Concentration:25 μM
-
Incubation Time:48 h
-
Result:Induced total apoptosis in approximately 40% of T-47D cells.
Showed early and late apoptotic populations lower than those induced by compound 21 and bazedoxifene but higher than those induced by tamoxifen.
化学情報
-
分子量 427.45
-
分子式 C25H21N3O4
-
SMILES
O=[N+](C1=CC(C2=NOC(C3=CN(CC4=CC=CC(OC)=C4)C5=C3C=CC=C5)C2)=CC=C1)[O-]
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)